microdosing glp-1 receptor agonists Why Microdosing? A Closer Look at Reported Benefits Microdosing GLP-1s: How (and Why)

Tortorici Shirley M

To do this naturally, our body produces GHRH

Eckardt have received research grant support from Dicerna Pharmaceuticals, Cambridge, MA, U.S.A

B12 injections are clinically indicated for specific patient groups with documented deficiency or conditions affecting B12 absorption

Future Directions and Research Opportunities Triple Agonism and Beyond The success of dual agonism has stimulated interest in triple agonism approaches that add glucagon receptor activation to GIP and GLP-1 targeting

Statistical significance was tested using an unpaired two-tailed Students t test, a MannWhitney U test, a one-way or two-way ANOVA with Bonferroni correction or a KruskalWallis test followed by Dunns correction as indicated in the figure legend